|
| 36640796 | 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection. | Lancet Infect Dis | 2023 |
| 37702366 | An easy-to-use high-throughput selection system for the discovery of recombinant protein binders from alternative scaffold libraries. | Protein Eng Des Sel | 2023 |
| 35859351 | Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys. | J Infect Dis | 2023 |
| 37086736 | Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose. | Lancet Microbe | 2023 |
| 36949041 | Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers. | Nat Commun | 2023 |
| 37175001 | The GRPR Antagonist [<sup>99m</sup>Tc]Tc-maSSS-PEG<sub>2</sub>-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity. | Diagnostics (Basel) | 2023 |
| 37370758 | Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [<sup>99m</sup>Tc]Tc-ADAPT6 and [<sup>99m</sup>Tc]Tc-(HE)<sub>3</sub>-G3, for Imaging of HER2-Positive Breast Cancer. | Cancers (Basel) | 2023 |
| 36871527 | Calcium-dependent affinity ligands for the purification of antibody fragments at neutral pH. | J Chromatogr A | 2023 |
| 34564699 | Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients. | Leukemia | 2022 |
| 35808856 | B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients. | Eur J Neurol | 2022 |
| 35444806 | Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time. | Clin Transl Immunology | 2022 |
| 35349756 | Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology. | Immun Inflamm Dis | 2022 |
| 35470430 | Integrated continuous biomanufacturing on pilot scale for acid-sensitive monoclonal antibodies. | Biotechnol Bioeng | 2022 |
| 35691303 | Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection. | Lancet Infect Dis | 2022 |
| 36499504 | Direct In Vivo Comparison of <sup>99m</sup>Tc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy. | Int J Mol Sci | 2022 |
| 36450334 | CaRA - A multi-purpose phage display library for selection of calcium-regulated affinity proteins. | N Biotechnol | 2022 |
| 36103621 | Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection. | N Engl J Med | 2022 |
| 35986481 | A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells. | EMBO Mol Med | 2022 |
| 36015242 | Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart. | Pharmaceutics | 2022 |
| 35947447 | Correction to "Small Bispecific Affinity Proteins for Simultaneous Target Binding and Albumin-Associated Half-Life Extension". | Mol Pharm | 2022 |
| 35075450 | Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals. | Med | 2022 |
| 35033788 | Design of an integrated continuous downstream process for acid-sensitive monoclonal antibodies based on a calcium-dependent Protein A ligand. | J Chromatogr A | 2022 |
| 35334989 | Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines. | Vaccines (Basel) | 2022 |
| 35020778 | SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection. | PLoS One | 2022 |
| 34459525 | Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19. | J Intern Med | 2022 |
| 34628049 | A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies. | N Biotechnol | 2022 |
| 32817142 | Phase I Study of <sup>99m</sup>Tc-ADAPT6, a Scaffold Protein-Based Probe for Visualization of HER2 Expression in Breast Cancer. | J Nucl Med | 2021 |
| 33825846 | Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. | JAMA | 2021 |
| 33843090 | SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden. | J Intern Med | 2021 |
| 33664279 | Antibodies to SARS-CoV-2 and risk of past or future sick leave. | Sci Rep | 2021 |
| 33580261 | High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers. | J Infect Dis | 2021 |
| 34861491 | Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial. | EBioMedicine | 2021 |
| 34408239 | Secretome screening reveals immunomodulating functions of IFNα-7, PAP and GDF-7 on regulatory T-cells. | Sci Rep | 2021 |
| 34490414 | Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis. | iScience | 2021 |
| 34391088 | Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2. | EBioMedicine | 2021 |
| 34834262 | Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein. | Pharmaceutics | 2021 |
| 34591918 | An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses. | PLoS One | 2021 |
| 34295471 | Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay. | Clin Transl Immunology | 2021 |
| 34012450 | False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases. | Front Immunol | 2021 |
| 34148454 | Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care. | Scand J Public Health | 2021 |
| 33978762 | Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys. | J Infect Dis | 2021 |
| 34369763 | Affinity-Based Methods for Site-Specific Conjugation of Antibodies. | Bioconjug Chem | 2021 |
| 33128754 | Z<sub>Ca</sub>: A Protein A-Derived Domain with Calcium-Dependent Affinity for Mild Antibody Purification. | Methods Mol Biol | 2021 |
| 33128750 | An Orthogonal Fusion Tag for Efficient Protein Purification. | Methods Mol Biol | 2021 |
| 33128749 | Z<sub>basic</sub>: A Purification Tag for Selective Ion-Exchange Recovery. | Methods Mol Biol | 2021 |
| 33412291 | Highly selective Protein A resin allows for mild sodium chloride-mediated elution of antibodies. | J Chromatogr A | 2021 |
| 33259222 | Small Bispecific Affinity Proteins for Simultaneous Target Binding and Albumin-Associated Half-Life Extension. | Mol Pharm | 2021 |
| 33120197 | Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle. | Biomaterials | 2021 |
| 32425085 | Secretome-Based Screening in Target Discovery. | SLAS Discov | 2020 |
| 33033249 | SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. | Nat Commun | 2020 |